Aarti Drugs Limited (NSE:AARTIDRUGS)

Aarti Drugs Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	94.32	89.6	223.3	97.79	76.42
Short-Term Investments	-	108.89	113.3	120.51	122.05	114.23
Cash & Short-Term Investments	295.6	203.2	202.89	343.81	219.84	190.65
Cash Growth	18.29%	0.15%	-40.99%	56.39%	15.31%	31.69%
Accounts Receivable	-	7,046	8,648	7,499	5,552	4,886
Other Receivables	-	47.17	39.11	6.98	24.37	22.7
Receivables	-	7,095	8,691	7,506	5,577	4,909
Inventory	-	4,859	5,163	5,259	4,150	3,254
Other Current Assets	-	1,050	861.42	824.5	621.43	686.27
Total Current Assets	-	13,207	14,918	13,934	10,568	9,040
Property, Plant & Equipment	-	10,351	8,622	7,665	6,844	6,545
Long-Term Investments	-	199.74	187.99	194.8	173.01	133.62
Other Intangible Assets	-	368.24	243.34	1.53	2.55	14.92
Other Long-Term Assets	-	197.04	242.33	284.36	72.61	31.19
Total Assets	-	24,324	24,214	22,080	17,660	15,765
Accounts Payable	-	4,496	4,925	4,687	3,300	3,295
Accrued Expenses	-	71.78	91.65	76.77	171.92	74.74
Short-Term Debt	-	2,147	3,605	3,563	1,572	1,577
Current Portion of Long-Term Debt	-	723.83	412.96	435	396.08	413.03
Current Portion of Leases	-	9.5	19.92	25.97	27.97	34.2
Current Income Taxes Payable	-	11.81	42.33	-	-	-
Other Current Liabilities	-	495.39	397.13	612.7	485.77	837.17
Total Current Liabilities	-	7,955	9,495	9,401	5,954	6,232
Long-Term Debt	-	2,753	2,047	1,385	1,476	1,803
Long-Term Leases	-	9.14	4.03	18.79	35.8	58.72
Long-Term Unearned Revenue	-	1.7	1.7	1.7	1.7	1.7
Long-Term Deferred Tax Liabilities	-	757.07	709.68	724.31	771.34	807.14
Other Long-Term Liabilities	-	-0	-	157.45	269.89	322.07
Total Liabilities	-	11,504	12,287	11,717	8,526	9,240
Common Stock	-	919.35	926	926	932	233
Retained Earnings	-	11,701	10,811	9,240	8,018	6,141
Comprehensive Income & Other	-	194.75	187.48	197.4	184.54	150.45
Total Common Equity	12,774	12,815	11,924	10,364	9,134	6,525
Minority Interest	-	4.06	2.33	-0.6	-0.17	-0.02
Shareholders' Equity	12,778	12,820	11,927	10,363	9,134	6,525
Total Liabilities & Equity	-	24,324	24,214	22,080	17,660	15,765
Total Debt	5,901	5,643	6,089	5,428	3,508	3,886
Net Cash (Debt)	-5,605	-5,440	-5,886	-5,084	-3,288	-3,696
Net Cash Per Share	-61.31	-59.17	-63.57	-54.91	-35.28	-39.65
Filing Date Shares Outstanding	91.27	91.94	92.6	92.6	93.2	93.2
Total Common Shares Outstanding	91.27	91.94	92.6	92.6	93.2	93.2
Working Capital	-	5,252	5,423	4,533	4,614	2,808
Book Value Per Share	139.96	139.40	128.77	111.92	98.01	70.01
Tangible Book Value	12,752	12,447	11,681	10,362	9,132	6,510
Tangible Book Value Per Share	139.71	135.39	126.14	111.90	97.98	69.85
Land	-	937.67	937.67	934.6	649.81	356.28
Buildings	-	2,257	1,932	1,921	1,882	1,834
Machinery	-	10,633	9,122	8,792	8,383	8,017
Construction In Progress	-	2,252	1,868	767.37	192.57	122.06

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.